The Valley Desk

NCT02650999 · Interventional trial

Pembrolizumab in Patients Failing to Respond to or Relapsing After CAR T Cell Therapy for Relapsed or Refractory Lymphomas

Overall registry status Completed

Phase 1 · Phase 2

Conditions CD19+ Diffuse Large B-cell Lymphomas, Follicular Lymphomas, Mantle Cell Lymphomas

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov